Literature DB >> 30721381

Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications.

Takuya Aoki1,2, Yosuke Yamamoto3,4, Tatsuyoshi Ikenoue2,5, Shunichi Fukuhara1,6,7.   

Abstract

Background Deprescribing is a patient-centered intervention with inherent uncertainties and requires shared decision making and patient involvement. Objective In the present study, we aimed to investigate factors associated with patient preferences toward deprescribing in a representative sample in Japan. Methods We conducted a nationwide cross-sectional survey and used a quota sampling method to select representative samples of the Japanese general population. We collected data on participant demographic and clinical factors including the number of chronic health conditions and the number of regular prescription medications. Patients' willingness to deprescribe was assessed using the patients' attitudes towards deprescribing questionnaire. Multivariable logistic regression analyses were conducted to determine factors associated with the outcome measure. Results Data were analyzed for 1483 adult outpatients. The proportion of patients having willingness to deprescribe was 67.8%. After adjustment for age and gender, multimorbidity was significantly positively associated with patients' willingness to deprescribe [adjusted odds ratio (aOR) 1.35; 95% confidence interval (CI) 1.06-1.72]. A similar association was found with polypharmacy (aOR 1.43; 95% CI 1.08-1.88). The number of visits to medical institutions and increasing age were also found to be associated with patients' willingness to deprescribe. Conclusion Our study indicated that patient preferences towards deprescribing are consistent with the established clinical evidence regarding the efficacy of deprescribing for patients with multimorbidity and polypharmacy. These findings may be beneficial for health care providers to implement shared decision making regarding deprescribing effectively.

Entities:  

Keywords:  Chronic disease; Decision making; Deprescribing; Japan; Multimorbidity; Patient preference; Polypharmacy

Mesh:

Year:  2019        PMID: 30721381     DOI: 10.1007/s11096-019-00797-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  22 in total

1.  People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.

Authors:  Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

2.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

3.  Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire.

Authors:  Emily Reeve; Sepehr Shakib; Ivanka Hendrix; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2012-10-09

4.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

5.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

6.  Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study.

Authors:  Christopher Beer; Zoë Hyde; Osvaldo P Almeida; Paul Norman; Graeme J Hankey; Bu B Yeap; Leon Flicker
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

7.  Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

Authors:  Amaia Calderón-Larrañaga; Beatriz Poblador-Plou; Francisca González-Rubio; Luis Andrés Gimeno-Feliu; José María Abad-Díez; Alexandra Prados-Torres
Journal:  Br J Gen Pract       Date:  2012-12       Impact factor: 5.386

Review 8.  Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

9.  Medication quality and quality of life in the elderly, a cohort study.

Authors:  Inger Nordin Olsson; Rebecka Runnamo; Peter Engfeldt
Journal:  Health Qual Life Outcomes       Date:  2011-11-03       Impact factor: 3.186

10.  Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform.

Authors:  Viet-Thi Tran; Magdalena Harrington; Victor M Montori; Caroline Barnes; Paul Wicks; Philippe Ravaud
Journal:  BMC Med       Date:  2014-07-02       Impact factor: 8.775

View more
  13 in total

1.  One-year persistence of potentially inappropriate medication use in older adults: A population-based study.

Authors:  Barbara Roux; Caroline Sirois; Marc Simard; Marie-Eve Gagnon; Marie-Laure Laroche
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

Review 2.  Patient values and preferences on polypharmacy and deprescribing: a scoping review.

Authors:  Evan Forest; Melissa Ireland; Uma Yakandawala; Teresa Cavett; Lalitha Raman-Wilms; Jamie Falk; Diana McMillan; Rhys Linthorst; Leanne Kosowan; Lisa Labine; Christine Leong
Journal:  Int J Clin Pharm       Date:  2021-09-22

3.  Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study.

Authors:  Erin E Hahn; Corrine E Munoz-Plaza; Eric Anthony Lee; Tiffany Q Luong; Brian S Mittman; Michael H Kanter; Hardeep Singh; Kim N Danforth
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 6.473

4.  Attitudes Toward Deprescribing in Older Adults and Caregivers: A Survey in Quebec, Canada.

Authors:  Bianca Rakheja; Caroline Sirois; Nicole Ouellet; Barbara Roux; Marie-Laure Laroche
Journal:  J Appl Gerontol       Date:  2022-03-04

5.  Exploring Patients' Attitudes Toward Deprescribing and Their Perception of Pharmacist Involvement in a European Country: A Cross-Sectional Study.

Authors:  Iva Bužančić; Patricia Dragović; Tajana Iva Pejaković; Luka Markulin; Maja Ortner-Hadžiabdić
Journal:  Patient Prefer Adherence       Date:  2021-09-23       Impact factor: 2.711

6.  Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies.

Authors:  Mikkel Bring Christensen; Anne Frølich; Christian Ulrich Eriksen; Stavros Kyriakidis; Line Due Christensen; Ramune Jacobsen; Jannie Laursen
Journal:  BMJ Open       Date:  2020-09-06       Impact factor: 2.692

7.  Physical multimorbidity patterns and depressive symptoms: a nationwide cross-sectional study in Japan.

Authors:  Takuya Aoki; Yosuke Yamamoto; Sayaka Shimizu; Shunichi Fukuhara
Journal:  Fam Med Community Health       Date:  2020-01-05

8.  What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.

Authors:  Zsofia Rozsnyai; Katharina Tabea Jungo; Emily Reeve; Rosalinde K E Poortvliet; Nicolas Rodondi; Jacobijn Gussekloo; Sven Streit
Journal:  BMC Geriatr       Date:  2020-10-31       Impact factor: 3.921

9.  Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study.

Authors:  François-Xavier Sibille; Anne Spinewine; Lorène Zerah; Laurentine Maljean; Didier Schoevaerdts; Marie de Saint-Hubert
Journal:  BMC Geriatr       Date:  2022-02-01       Impact factor: 3.921

10.  How Willing Are Patients or Their Caregivers to Deprescribe: a Systematic Review and Meta-analysis.

Authors:  Yee Lin Chock; Yuan Lin Wee; Su Lene Gan; Kah Woon Teoh; Khuen Yen Ng; Shaun Wen Huey Lee
Journal:  J Gen Intern Med       Date:  2021-06-25       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.